COMPANY
Sialia Therapeutics, Inc.
Biotechnology company (SEC Form D industry: Biotechnology); no public description yet. Source · checked Oct 14, 2026
Sourced facts
Funding (SEC filing)
- SEC Form D filed Sep 29, 2026: $1,500,000 sold · sec.gov · checked Oct 14, 2026
Funding and NIH signals
- SEC Form D raise Raised $1.5M (Form D filed Sep 29, 2026). SEC Form D 0002156754-26-000001 (Sep 29, 2026)
Evidence (1 event)
- Sep 29, 2026 · SEC Form D 0002156754-26-000001
Name of Issuer: Sialia Therapeutics, Inc.; CIK: 2156754; Address: Irvine, CA; Submission type: D; Filing date: 2026-09-29; Industry Group: Biotechnology; Date of First Sale: 2026-09-02; Types of Securities Offered: Option/warrant; Business combination transaction: false; Total Offering Amount: 1500000; Total Amount Sold: 1500000; Federal exemptions: 06b
- Sep 29, 2026 · SEC Form D 0002156754-26-000001